Clinical Trials Logo

Clinical Trial Summary

About 1 to 3% of women of childbearing age have repeated early spontaneous miscarriages (RCF) defined by at least 3 fetal losses before 14 weeks of gestation. RCFs may be related to parental chromosomal abnormalities, congenital or acquired uterine abnormalities, hormonal causes (e.g. type 1 and 2 diabetes, ovarian failure), infectious etiology, constitutional or acquired thrombophilia or sickle cell disease. The presence of antiphospholipid antibodies, antithyroid and anti-transglutaminase antibodies in approximately 10% of cases suggests an autoimmune origin for these fetal losses. The role of other antibodies, in particular unconventional antiphospholipid antibodies, remains to be established. Indeed half of RCF cases would be due to an immunological dysregulation of the mother leading to a decrease in tolerance to the fetus. Several studies have shown immune abnormalities, such as an imbalance of pro and anti-inflammatory cytokines, an increase in cytotoxic cells and a defect in regulatory cells in the blood of patients. The assessment of these immune abnormalities is not currently carried out routinely in France in women with recurrent early miscarriages. When one of these known causes is excluded, it is unexplained RCF which represents 50% of RCF. In these women with unexplained RCF, slightly more than half could be linked to aneuploidies and primary recurrent spontaneous abortions. The evaluation of the degree of aneuploidy and the genetic origin of fetal losses remains difficult, the examination of the sample of tissue from the miscarriage being rarely available, due to the spontaneous nature of the loss. The constitution of a prospective cohort of patients with RCF is an essential step in exploring the factors associated with the success of treatment.


Clinical Trial Description

On the day of inclusion, if the patient accepts the ancillary study, a blood sample will be taken for the biological collection If the patient becomes pregnant during the follow-up period, the blood sample for the ancillary study will be repeated each trimester of pregnancy (if applicable). At the inclusion visit and during pregnancy, the patient will complete a Baecke questionnaire and a questionnaire to measure perceived stress The study population will be followed as part of usual care, identical to all patients presenting with RCF. As part of the routine care of the internal medicine department of Saint Antoine, patients with RCF have a complete check-up in the day hospital (complete blood test, stomatologist consultation, ECG) and are seen in consultation twice a year. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05557201
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact Arsene MEKINIAN, MD, PhD
Phone 1 71 97 07 65
Email arsene.mekinian@aphp.fr
Status Not yet recruiting
Phase
Start date October 2022
Completion date October 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05969574 - Is Decreased Ovarian Reserve Related to an Increased Number of Previous Early Miscarriages?
Enrolling by invitation NCT01689428 - Ism1 Versus EmbryoGen Media for Embryo Culture in Previous Pregnancy Loss Cases Phase 3
Completed NCT00194844 - Couples Miscarriage Healing Project:Randomized Trial Phase 1/Phase 2
Recruiting NCT05789940 - Hysteroscopy vs. Endouterine Aspiration in the Management of Trophoblastic Retention N/A
Recruiting NCT03628625 - Letrozole Pretreatment With Misoprostol fInduction of Abortion In First-Trimester Missed Miscarriage Phase 2
Not yet recruiting NCT05579756 - Psychatric Impact of Miscarriage in Assiut University Hospital
Not yet recruiting NCT05039853 - Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task N/A
Recruiting NCT01223482 - A Study Looking at Women's Experiences After a Miscarriage N/A
Completed NCT04604366 - Comparison of Vaginal Versus Sublingual Misoprostol in the Treatment of First Trimester Missed Miscarriage Phase 2
Not yet recruiting NCT05088720 - Misoprostol for Management of Women With an Incomplete Miscarriage N/A
Not yet recruiting NCT05088707 - Sublingual Versus Vaginal Misoprostol In Medical Treatment of Second Trimestric Missed Miscarriage N/A
Not yet recruiting NCT05094375 - Vaginal Misoprostol In Medical Treatment of First Trimester Missed Miscarriage N/A
Not yet recruiting NCT05103098 - Sublingual Misoprostol In Medical Treatment of First Trimester Missed Miscarriage N/A
Recruiting NCT05304273 - Comparison Between Letrozole and Mifepristone in Medical Termination of First Trimester Miscarriages Phase 3
Not yet recruiting NCT05653414 - Interest of a Short Early Psychological Care in Women With Miscarriage N/A
Recruiting NCT03976544 - Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients Phase 4
Completed NCT01916928 - The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage N/A
Completed NCT03940495 - Serum Kisspeptin: a Predictive Marker of Miscarriage or Not?
Completed NCT04512820 - Treatment of Missed Miscarriage With TRUCLEAR Tissue Removal System, a Feasiblity Study N/A
Recruiting NCT05762770 - A Trial of Sperm Injection (PICSI) on Miscarriage Rates in Assisted Conception N/A